Neurosense Therapeutics Ltd (NRSN) Stock Split History

Neurosense Therapeutics Ltd has split its stock once since its initial public offering (IPO). The stock split of Neurosense Therapeutics Ltd occurred on September 14, 2026 on a 1-for-20 basis, meaning that for 20 shares of NRSN owned pre-split, shareholders then owned 1 share.

This action has increased the stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that a stock split only changes the number of shares and the price per share with no impact on Neurosense Therapeutics Ltd's total market capitalization.

The answer will depend on the decisions of the company's managers and market volatility. Neurosense Therapeutics Ltd has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when NRSN stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Neurosense Therapeutics Ltd's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.